Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction

PLoS ONE(2020)10.1371/journal.pone.0233161Source: DataRank Database

Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.15)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Melissa K. Van Dyke ORCID,Ligong Chen,Todd M. Brown ORCID,Raegan W. Durant ORCID,Monika M. Safford ORCID

Live enrichment

PubMed:32645049 PMC:PMC7347167 OpenAlex:https://openalex.org/W3041125101

National Heart, Lung, and Blood Institute

Grant: 5T32HL00745734

Amgen

FWCI

0.15

Citation Percentile

0.5%

Citation Trend

2022

2024

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233161&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233161&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0233161

journalhttps://doi.org/10.1371/journal.pone.0233161

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32645049

Fields of Study

Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsPotassium and Related DisordersAnimalsAstrocytesAstrocytomaCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell LineCyclic AMP Response Element-Binding ProteinCysteine-Rich Protein 61HumansMiceMice, Inbred C57BLPhosphorylationSerine EndopeptidasesUp-RegulationViral Nonstructural ProteinsViral ProteinsVirus ReplicationZika VirusZika Virus InfectionNucleoside-TriphosphataseDEAD-box RNA HelicasesViral Proteases

MeSH Terms

Zika Virus InfectionZika VirusViral ProteasesAnimalsAstrocytesAstrocytomaCell LineHumansMice, Inbred C57BLPhosphorylationSerine EndopeptidasesViral ProteinsVirus ReplicationUp-RegulationViral Nonstructural ProteinsCyclic AMP Response Element-Binding ProteinNucleoside-TriphosphataseMiceDEAD-box RNA HelicasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Cysteine-Rich Protein 61

Keywords

MedicineHeart failureHazard ratioEjection fractionBisoprololCarvedilolInternal medicineBeta blockerProportional hazards modelCardiologyRetrospective cohort studyConfidence intervalMedical prescriptionEmergency medicinePharmacology

Sustainable Development Goals

SDG 0: Good health and well-being